Life Sciences

States, Bayer settle case alleging deceptive advertising

Pharma Compliance Alert, February 11, 2009

Bayer entered into a settlement with 27 states to resolve allegations it deceptively marketed its oral contraceptive Yaz, according to a press release from Massachusetts Attorney General Martha Coakley.

In 2007, Bayer reached an agreement to resolve allegations of deceptive advertising of products, including non-disclosure of safety risks associated with its marketing of Baycol. The 2008 settlement resolves allegations that Bayer violated the terms of the 2007 agreement by not disclosing the FDA approved uses of Yaz.

Read more about Bayer's settlement for alleged deceptive advertising.

Most Popular